BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, Giovannucci EL, Hunter DJ. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer. 2006;119:1863-1868. [PMID: 16721787 DOI: 10.1002/ijc.22057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Sindi IA, Babalghith AO, Tayeb MT, Mufti AH, Naffadi H, Ekram SN, Elhawary EN, Alenezi M, Elhawary NA. Risk of Colorectal Carcinoma May Predispose to the Genetic Variants of the GST, CYP450, and TP53 Genes Among Nonsmokers in the Saudi Community. Int J Gen Med 2021;14:1311-23. [PMID: 33883929 DOI: 10.2147/IJGM.S294802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Elshazli RM, Toraih EA, Elgaml A, Kandil E, Fawzy MS. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene 2020;734:144391. [PMID: 32001373 DOI: 10.1016/j.gene.2020.144391] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
3 Soler DC, Manikandan M, Gopal SR, Sloan AE, McCormick TS, Stepanyan R. An uncharacterized region within the N-terminus of mouse TMC1 precludes trafficking to plasma membrane in a heterologous cell line. Sci Rep 2019;9:15263. [PMID: 31649296 DOI: 10.1038/s41598-019-51336-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Zhang G, Xu Q, Liu J, Lv Z, Lu Y, Yang H, Sun L, Xing C, Yuan Y. Five P53 SNPs Involved in Low Rectal Cancer Risk and Prognosis in a Chinese Population. J Cancer 2019;10:1772-80. [PMID: 31205533 DOI: 10.7150/jca.26722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Stoehr R, Weisser R, Wendler O, Giedl J, Daifalla K, Gaisa NT, Richter G, Campean V, Burger M, Wullich B, Hartmann A. P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study. J Cancer 2018;9:4234-41. [PMID: 30519324 DOI: 10.7150/jca.26050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Elsaid A, Zahran R, Elshazli R, El-sayed A, Abou Samra M, El-tarapely F, Abdel-malak C. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma. Archives of Physiology and Biochemistry 2018;125:255-62. [DOI: 10.1080/13813455.2018.1453522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tian X, Dai S, Sun J, Jiang S, Jiang Y. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies. Oncotarget 2017;8:1156-65. [PMID: 27901479 DOI: 10.18632/oncotarget.13589] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
8 Rivu SF, Apu MNH, Shabnaz S, Nahid NA, Islam MR, Al-mamun MMA, Nahar Z, Rabbi SNI, Ahmed MU, Islam MS, Hasnat A. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population. Cancer Epidemiology 2017;49:46-52. [DOI: 10.1016/j.canep.2017.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
9 Hossain A, Murshid GMM, Zilani MNH, Islam F, Sultana R, Sultana T, Hossain MG, Rahman MM. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population. Breast Cancer 2017;24:571-8. [PMID: 27837441 DOI: 10.1007/s12282-016-0740-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
10 Tian C, Chen Z, Ma X, Yang M, Wang Z, Dong Y, Yang T, Yang W. Comparison of Genetic Variants in Cancer-Related Genes between Chinese Hui and Han Populations. PLoS One 2015;10:e0145170. [PMID: 26683024 DOI: 10.1371/journal.pone.0145170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Montazeri Z, Theodoratou E, Nyiraneza C, Timofeeva M, Chen W, Svinti V, Sivakumaran S, Gresham G, Cubitt L, Carvajal-Carmona L, Bertagnolli MM, Zauber AG, Tomlinson I, Farrington SM, Dunlop MG, Campbell H, Little J. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. Int J Epidemiol 2016;45:186-205. [PMID: 26451011 DOI: 10.1093/ije/dyv185] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
12 Volodko N, Salla M, Eksteen B, Fedorak RN, Huynh HQ, Baksh S. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development. World J Gastroenterol 2015; 21(36): 10358-10366 [PMID: 26420962 DOI: 10.3748/wjg.v21.i36.10358] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
13 Puerta-García E, Cañadas-Garre M, Calleja-Hernández MÁ. Molecular biomarkers in colorectal carcinoma. Pharmacogenomics 2015;16:1189-222. [PMID: 26237292 DOI: 10.2217/PGS.15.63] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
14 Abderrahmane R, Louhibi L, Moghtit FZ, Boubekeur A, Benseddik K, Boudjema A, Benrrahal F, Aberkane M, Fodil M, Saidi-mehtar N. TP53 Arg 72Pro and MDM2 SNP309 Polymorphisms and Colorectal Cancer Risk: A West Algerian Population Study. Pathol Oncol Res 2015;21:629-35. [DOI: 10.1007/s12253-014-9867-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
15 Mahmood S, Sivoňová M, Matáková T, Dobrota D, Wsólová L, Dzian A, Mištuna D. Association of EGF and p53 gene polymorphisms and colorectal cancer risk in the Slovak population. Open Medicine 2014;9:405-16. [DOI: 10.2478/s11536-013-0300-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Singamsetty GK, Malempati S, Bhogadhi S, Kondreddy R, Govatati S, Tangudu NK, Govatati S, kuraganti AK, Bhanoori M, Kassetty K. TP53 alterations and colorectal cancer predisposition in south Indian population: A case-control study. Tumor Biol 2014;35:2303-11. [DOI: 10.1007/s13277-013-1305-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
17 Mędrek K, Magnowski P, Masojć B, Chudecka-Głaz A, Torbe B, Menkiszak J, Spaczyński M, Gronwald J, Lubiński J, Górski B. Association of common WRAP 53 variant with ovarian cancer risk in the Polish population. Mol Biol Rep 2013;40:2145-7. [PMID: 23192612 DOI: 10.1007/s11033-012-2273-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
18 Di Pietro F, Dato S, Carpi FM, Corneveaux JJ, Serfaustini S, Maoloni S, Mignini F, Huentelman MJ, Passarino G, Napolioni V. TP53*P72 allele influences negatively female life expectancy in a population of central Italy: cross-sectional study and genetic-demographic approach analysis. J Gerontol A Biol Sci Med Sci 2013;68:539-45. [PMID: 23125046 DOI: 10.1093/gerona/gls223] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
19 Zhang Q, Ma YY, Wang HJ, Shao CM, Zhang J, Ye ZY. Meta-analysis of the association between P53 codon 72 polymorphisms and gastric cancer. J Surg Oncol. 2013;107:360-366. [PMID: 22886602 DOI: 10.1002/jso.23233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
20 Naccarati A, Polakova V, Pardini B, Vodickova L, Hemminki K, Kumar R, Vodicka P. Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis 2012;27:211-8. [PMID: 22294769 DOI: 10.1093/mutage/ger067] [Cited by in Crossref: 66] [Cited by in F6Publishing: 77] [Article Influence: 6.6] [Reference Citation Analysis]
21 Loeb KR, Asgari MM, Hawes SE, Feng Q, Stern JE, Jiang M, Argenyi ZB, de Villiers EM, Kiviat NB. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. PLoS One 2012;7:e34422. [PMID: 22545084 DOI: 10.1371/journal.pone.0034422] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
22 Engin AB, Karahalil B, Karakaya AE, Engin A. Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population. Arh Hig Rada Toksikol. 2011;62:207-214. [PMID: 21971103 DOI: 10.2478/10004-1254-62-2011-2098] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
23 Liu L, Wang K, Zhu ZM, Shao JH. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Arch Med Res 2011;42:60-9. [PMID: 21376265 DOI: 10.1016/j.arcmed.2011.01.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
24 Zhang R, Chen W, Zhang W, Jiang Q, Liu C, Lin Y, Hu Z, Yu S, Xu G. Genetic Polymorphisms of p 53 Codon 72 and Bladder Cancer Susceptibility: A Hospital-Based Case–Control Study. Genetic Testing and Molecular Biomarkers 2011;15:337-41. [DOI: 10.1089/gtmb.2010.0230] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
25 Song HR, Kweon SS, Kim HN, Piao JM, Yun WJ, Choi JS, Hwang JE, Yoon JY, Kim HR, Park YK. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer. 2011;14:242-248. [PMID: 21461655 DOI: 10.1007/s10120-011-0034-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
26 Chen X, Liu F, Li B, Wei YG, Yan LN, Wen TF. p53 codon 72 polymorphism and liver cancer susceptibility: A meta-analysis of epidemiologic studies. World J Gastroenterol 2011; 17(9): 1211-1218 [PMID: 21448428 DOI: 10.3748/wjg.v17.i9.1211] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
27 Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Dong JH, Zhang L, Xu J, Shi W, Ren YC. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis. Mol Biol Rep 2011;38:4847-53. [PMID: 21140221 DOI: 10.1007/s11033-010-0619-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
28 Joshi AM, Budhathoki S, Ohnaka K, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K. TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Jpn J Clin Oncol. 2011;41:232-238. [PMID: 21051533 DOI: 10.1093/jjco/hyq200] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
29 Zhou Y, Li N, Zhuang W, Wu X. p53 Codon 72 polymorphism and gastric cancer risk in a Chinese Han population. Genet Test Mol Biomarkers 2010;14:829-33. [PMID: 20939739 DOI: 10.1089/gtmb.2010.0115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
30 Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138:2044-2058. [PMID: 20420945 DOI: 10.1053/j.gastro.2010.01.054] [Cited by in Crossref: 725] [Cited by in F6Publishing: 795] [Article Influence: 60.4] [Reference Citation Analysis]
31 Tang NP, Wu YM, Wang B, Ma J. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol. 2010;36:431-438. [PMID: 20363586 DOI: 10.1016/j.ejso.2010.03.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
32 Eren F, Akkiprik M, Atuğ O, Sönmez O, Tahan G, Ozdemir F, Hamzaoğlu HO, Celikel CA, Imeryüz N, Avşar E, Ozer A. R72P polymorphism of TP53 in ulcerative colitis patients is associated with the incidence of colectomy, use of steroids and the presence of a positive family history. Pathol Oncol Res 2010;16:563-8. [PMID: 20309662 DOI: 10.1007/s12253-010-9255-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
33 Souček K, Gajdušková P, Brázdová M, Hýžd'alová M, Kočí L, Vydra D, Trojanec R, Pernicová Z, Lentvorská L, Hajdúch M, Hofmanová J, Kozubík A. Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation. Cancer Genetics and Cytogenetics 2010;197:107-16. [DOI: 10.1016/j.cancergencyto.2009.11.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
34 Do TN, Ucisik-akkaya E, Davis CF, Morrison BA, Dorak MT. TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. Cancer Genetics and Cytogenetics 2009;195:31-6. [DOI: 10.1016/j.cancergencyto.2009.05.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
35 Csejtei A, Tibold A, Ember I, Kiss I. [Genetic polymorphism in patients with colorectal and with head and neck cancer]. Orv Hetil 2009;150:1545-9. [PMID: 19643719 DOI: 10.1556/OH.2009.28634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Vora S, Ellis N, Onel K. Translating genetic questions into clinical answers in acute myeloid leukemia. Leuk Res 2009;33:1448-9. [PMID: 19631381 DOI: 10.1016/j.leukres.2009.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Iacopetta B, Heyworth J, Girschik J, Grieu F, Clayforth C, Fritschi L. The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer. Int J Cancer. 2009;125:84-90. [PMID: 19326430 DOI: 10.1002/ijc.24324] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
38 Polakova V, Pardini B, Naccarati A, Landi S, Slyskova J, Novotny J, Vodickova L, Bermejo JL, Hanova M, Smerhovsky Z, Tulupova E, Kumar R, Hemminki K, Vodicka P. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat 2009;30:661-8. [DOI: 10.1002/humu.20931] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
39 Arai T, Sawabe M, Hosoi T, Tanaka N. Role of DNA repair systems in malignant tumor development in the elderly. Geriatr Gerontol Int 2008;8:65-72. [DOI: 10.1111/j.1447-0594.2008.00450.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
40 Mammano E, Belluco C, Bonafé M, Olivieri F, Mugianesi E, Barbi C, Mishto M, Cosci M, Franceschi C, Lise M, Nitti D. Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. Eur J Surg Oncol 2009;35:415-9. [PMID: 18468835 DOI: 10.1016/j.ejso.2008.03.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
41 Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM, Larson RA, Allan JM, Onel K. MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood 2008;112:741-9. [PMID: 18426989 DOI: 10.1182/blood-2007-11-126508] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 4.6] [Reference Citation Analysis]
42 Shao Y, Tan W, Zhang S. P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Dis Esophagus 2008;21:139-43. [PMID: 18269649 DOI: 10.1111/j.1442-2050.2007.00746.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
43 Huang ZH, Hua D, Li LH, Zhu JD. Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy. J Cancer Res Clin Oncol. 2008;134:1129-1134. [PMID: 18357466 DOI: 10.1007/s00432-008-0380-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
44 Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer. 2007;121:1481-1486. [PMID: 17546594 DOI: 10.1002/ijc.22833] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 6.1] [Reference Citation Analysis]
45 Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Sakaguchi K, Shiratori Y. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol 2007;102:2259-64. [PMID: 17617203 DOI: 10.1111/j.1572-0241.2007.01404.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 3.0] [Reference Citation Analysis]
46 Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction? Pharmacogenet Genomics 2007;17:639-45. [PMID: 17622940 DOI: 10.1097/FPC.0b013e3280d5121c] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
47 Vietri MT, Riegler G, Ursillo A, Caserta L, Cioffi M, Molinari AM. p53 codon 72 polymorphism in patients affected with ulcerative colitis. J Gastroenterol. 2007;42:456-460. [PMID: 17671760 DOI: 10.1007/s00535-007-2026-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
48 Ezzikouri S, El Feydi AE, Chafik A, Benazzouz M, El Kihal L, Afifi R, Hassar M, Pineau P, Benjelloun S. The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population. Hepatol Res 2007;37:748-54. [PMID: 17573955 DOI: 10.1111/j.1872-034X.2007.00126.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
49 Perfumo C, Bonelli L, Menichini P, Inga A, Gismondi V, Ciferri E, Percivale P, Bianchi Scarrà G, Nasti S, Fronza G, Varesco L. Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the <i>p53</i> PIN3 A2-Pro72 Haplotype. Digestion 2007;74:228-35. [DOI: 10.1159/000100966] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
50 Savas S, Taylor IW, Wrana JL, Ozcelik H. Functional nonsynonymous single nucleotide polymorphisms from the TGF-β protein interaction network. Physiological Genomics 2007;29:109-17. [DOI: 10.1152/physiolgenomics.00226.2006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
51 Naccarati A, Pardini B, Hemminki K, Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res. 2007;635:118-145. [PMID: 17419091 DOI: 10.1016/j.mrrev.2007.02.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 4.0] [Reference Citation Analysis]